Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies

Hematologic malignancies (HMs) pose a serious threat to patients’ health and life, and the five-year overall survival of HMs remains low. The lack of understanding of the pathogenesis and the complex clinical symptoms brings immense challenges to the diagnosis and treatment of HMs. Traditional thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinxin, Wang, Qiwei, Han, Yingli, Jiang, Lingli, Lu, Siqi, Wang, Beini, Qian, Wenchang, Zhu, Meng, Huang, He, Qian, Pengxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290401/
https://www.ncbi.nlm.nih.gov/pubmed/37353849
http://dx.doi.org/10.1186/s13045-023-01460-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290401/
https://www.ncbi.nlm.nih.gov/pubmed/37353849
http://dx.doi.org/10.1186/s13045-023-01460-2

Ejemplares similares